![Andrew Oxtoby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Oxtoby
Directeur Général chez
Theia Therapeutics, Inc.
Fortune : - $ au 30/06/2026
Profil
Andrew Oxtoby is currently President, Chief Executive Officer & Director at Kalaris Therapeutics, Inc. since 2025.
Mr. Oxtoby is Chief Executive Officer & Director at Kalaris TX, Inc. since 2024.
Mr. Oxtoby is Director at Damien Center.
Formerly, Mr. Oxtoby was President & Chief Executive Officer at Aimmune Therapeutics, Inc. Mr. Oxtoby was VP-US Diabetes Sales, Connected Care & Insulins at Eli Lilly & Co. from 2015 to 2019.
Mr. Oxtoby was General Manager at Lilly Nederland.
Holding BV from 2009 to 2012.
Mr. Oxtoby was Chief Commercial Officer at Chinook Therapeutics, Inc. in 2023.
Mr. Oxtoby completed an undergraduate degree at Purdue University in 1996 and earned an MBA from Harvard Business School in 2002.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 01/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Andrew Oxtoby
| Sociétés | Poste | Début |
|---|---|---|
Damien Center
 Damien Center Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides support and treatment solutions for HIV prevention | Directeur/Membre du Conseil | - |
Theia Therapeutics, Inc.
 Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Directeur Général | 01/03/2024 |
Anciens postes connus de Andrew Oxtoby
| Sociétés | Poste | Fin |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 09/08/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2019 |
Lilly Nederland Holding BV
 Lilly Nederland Holding BV Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 01/04/2012 |
| AIMMUNE THERAPEUTICS, INC. | Directeur Général | - |
Formation de Andrew Oxtoby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Nederland Holding BV
Lilly Nederland Holding BV Financial ConglomeratesFinance Provides investment services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Theia Therapeutics, Inc.
Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Health Technology |
Damien Center
Damien Center Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides support and treatment solutions for HIV prevention | Commercial Services |
